Update: 01.04.2024
Last week: 12 week 2024 (18.03.2024 - 24.03.2024)
Last full month: February 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 194 | 1.8% | 10.4% | 0 | 18 414 810 | 2.5% | 8.9% | 0 | 2.0% |
| MoM | 29 171 | 8.3% | 11.0% | -0.1 | 65 772 614 | 9.3% | 9.5% | -0.1 | 9.6% |
| YTD | 82 887 | 25.4% | 11.0% | 2.4 | 186 180 594 | 57.4% | 9.5% | 2.2 | -1.5% |
| MAT | 357 632 | 34.6% | 9.6% | 1.7 | 724 698 058 | 48.5% | 8.2% | 1.4 | 10.6% |
| BRAINMAX | |||||||||
| WoW | 1 186 | 15.1% | 100.0% | 0 | 4 374 554 | 21.5% | 100.0% | 0 | 15.1% |
| MoM | 3 949 | -7.8% | 100.0% | 0 | 14 394 547 | -5.2% | 100.0% | 0 | -7.8% |
| YTD | 11 842 | 63.8% | 100.0% | 0 | 42 733 691 | 74.9% | 100.0% | 0 | 63.8% |
| MAT | 51 262 | 194.3% | 100.0% | NA | 179 295 694 | 213.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 18 091 | -6.1% | 44.1% | -0.9 | 56 311 016 | -8.0% | 35.0% | -1.2 | -4.2% |
| MoM | 68 306 | 1.9% | 43.8% | 0.3 | 217 517 575 | -1.1% | 35.9% | -0.2 | 1.2% |
| YTD | 196 972 | 3.5% | 43.9% | 2.1 | 632 004 058 | 10.4% | 36.0% | -1.9 | -1.3% |
| MAT | 875 769 | 21.2% | 45.4% | 2.2 | 2 751 431 058 | 30.4% | 39.1% | 1.3 | 15.4% |
| MIGRENIUM | |||||||||
| WoW | 11 655 | -4.8% | 0.5% | 0 | 3 579 108 | -4.4% | 0.7% | 0 | -2.5% |
| MoM | 53 054 | 6.6% | 0.6% | 0.1 | 15 088 199 | 15.2% | 0.7% | 0.1 | -6.1% |
| YTD | 144 240 | -2.0% | 0.5% | -0.1 | 40 715 405 | 53.8% | 0.6% | 0.1 | 22.8% |
| MAT | 638 703 | 8.9% | 0.5% | 0 | 136 905 744 | 29.0% | 0.5% | 0 | 16.2% |
| MODELAX-N | |||||||||
| WoW | 36 668 | -0.6% | 26.8% | 0 | 15 336 935 | -0.6% | 17.3% | 0 | -0.5% |
| MoM | 129 731 | 8.5% | 23.0% | 2.9 | 53 054 568 | 12.2% | 14.2% | 2.2 | -5.0% |
| YTD | 376 181 | 61.9% | 23.2% | 5.7 | 153 316 427 | 107.3% | 14.3% | 4.3 | 21.8% |
| MAT | 1 311 733 | 121.8% | 20.0% | 8.8 | 462 180 338 | 136.4% | 11.4% | 5.1 | 24.7% |
| REDUXIN | |||||||||
| WoW | 13 902 | -1.9% | 33.9% | 0.8 | 78 016 496 | -1.8% | 48.4% | 1.4 | -4.2% |
| MoM | 51 307 | -2.3% | 32.9% | -1.2 | 277 156 731 | -2.7% | 45.7% | -1 | 1.2% |
| YTD | 149 917 | -6.4% | 33.4% | -1.8 | 815 001 168 | 24.5% | 46.4% | 3 | -1.3% |
| MAT | 627 626 | 4.0% | 32.5% | -3.6 | 3 033 331 963 | 20.7% | 43.1% | -1.9 | 15.4% |
| REDUXIN FORTE | |||||||||
| WoW | 3 410 | -9.3% | 8.3% | -0.5 | 14 393 754 | -10.0% | 8.9% | -0.5 | -4.2% |
| MoM | 14 156 | 9.0% | 9.1% | 0.7 | 63 823 923 | 12.0% | 10.5% | 1.2 | 1.2% |
| YTD | 39 281 | 9.2% | 8.8% | 0.8 | 173 073 641 | 30.0% | 9.9% | 1 | -1.3% |
| MAT | 169 324 | 32.9% | 8.8% | 1.2 | 693 434 802 | 43.6% | 9.9% | 1.2 | 15.4% |
| SALVISAR | |||||||||
| WoW | 12 231 | -2.3% | 1.6% | 0 | 4 803 622 | -3.4% | 1.4% | 0 | -1.2% |
| MoM | 35 330 | 4.5% | 1.1% | 0.1 | 13 170 717 | 12.2% | 1.0% | 0.1 | -3.3% |
| YTD | 108 790 | -17.5% | 1.2% | -0.4 | 40 579 395 | -4.5% | 1.0% | -0.3 | 8.3% |
| MAT | 475 321 | -21.9% | 1.2% | -0.4 | 161 847 960 | -21.9% | 1.0% | -0.4 | 8.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 82 887 | 25.4% | 11.0% | 2.4 | 186 180 594 | 57.4% | 9.5% | 2.2 | -1.5% |
| BRAINMAX | 11 842 | 63.8% | 100.0% | 0 | 42 733 691 | 74.9% | 100.0% | 0 | 63.8% |
| GOLDLINE PLUS | 196 972 | 3.5% | 43.9% | 2.1 | 632 004 058 | 10.4% | 36.0% | -1.9 | -1.3% |
| MIGRENIUM | 144 240 | -2.0% | 0.5% | -0.1 | 40 715 405 | 53.8% | 0.6% | 0.1 | 22.8% |
| MODELAX-N | 376 181 | 61.9% | 23.2% | 5.7 | 153 316 427 | 107.3% | 14.3% | 4.3 | 21.8% |
| REDUXIN CAPS | 149 917 | -6.4% | 33.4% | -1.8 | 815 001 168 | 24.5% | 46.4% | 3 | -1.3% |
| REDUXIN FORTE | 39 281 | 9.2% | 8.8% | 0.8 | 173 073 641 | 30.0% | 9.9% | 1 | -1.3% |
| SALVISAR | 108 790 | -17.5% | 1.2% | -0.4 | 40 579 395 | -4.5% | 1.0% | -0.3 | 8.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 357 632 | 34.6% | 9.6% | 1.7 | 724 698 058 | 48.5% | 8.2% | 1.4 | 10.6% |
| BRAINMAX | 51 262 | 194.3% | 100.0% | NA | 179 295 694 | 213.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | 875 769 | 21.2% | 45.4% | 2.2 | 2 751 431 058 | 30.4% | 39.1% | 1.3 | 15.4% |
| MIGRENIUM | 638 703 | 8.9% | 0.5% | 0 | 136 905 744 | 29.0% | 0.5% | 0 | 16.2% |
| MODELAX-N | 1 311 733 | 121.8% | 20.0% | 8.8 | 462 180 338 | 136.4% | 11.4% | 5.1 | 24.7% |
| REDUXIN CAPS | 627 626 | 4.0% | 32.5% | -3.6 | 3 033 331 963 | 20.7% | 43.1% | -1.9 | 15.4% |
| REDUXIN FORTE | 169 324 | 32.9% | 8.8% | 1.2 | 693 434 802 | 43.6% | 9.9% | 1.2 | 15.4% |
| SALVISAR | 475 321 | -21.9% | 1.2% | -0.4 | 161 847 960 | -21.9% | 1.0% | -0.4 | 8.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 194 | 1.8% | 10.4% | 0 | 18 414 810 | 2.5% | 8.9% | 0 | 2.0% |
| BRAINMAX | 1 186 | 15.1% | 100.0% | 0 | 4 374 554 | 21.5% | 100.0% | 0 | 15.1% |
| GOLDLINE PLUS | 18 091 | -6.1% | 44.1% | -0.9 | 56 311 016 | -8.0% | 35.0% | -1.2 | -4.2% |
| MIGRENIUM | 11 655 | -4.8% | 0.5% | 0 | 3 579 108 | -4.4% | 0.7% | 0 | -2.5% |
| MODELAX-N | 36 668 | -0.6% | 26.8% | 0 | 15 336 935 | -0.6% | 17.3% | 0 | -0.5% |
| REDUXIN CAPS | 13 902 | -1.9% | 33.9% | 0.8 | 78 016 496 | -1.8% | 48.4% | 1.4 | -4.2% |
| REDUXIN FORTE | 3 410 | -9.3% | 8.3% | -0.5 | 14 393 754 | -10.0% | 8.9% | -0.5 | -4.2% |
| SALVISAR | 12 231 | -2.3% | 1.6% | 0 | 4 803 622 | -3.4% | 1.4% | 0 | -1.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 29 171 | 8.3% | 11.0% | -0.1 | 65 772 614 | 9.3% | 9.5% | -0.1 | 9.6% |
| BRAINMAX | 3 949 | -7.8% | 100.0% | 0 | 14 394 547 | -5.2% | 100.0% | 0 | -7.8% |
| GOLDLINE PLUS | 68 306 | 1.9% | 43.8% | 0.3 | 217 517 575 | -1.1% | 35.9% | -0.2 | 1.2% |
| MIGRENIUM | 53 054 | 6.6% | 0.6% | 0.1 | 15 088 199 | 15.2% | 0.7% | 0.1 | -6.1% |
| MODELAX-N | 129 731 | 8.5% | 23.0% | 2.9 | 53 054 568 | 12.2% | 14.2% | 2.2 | -5.0% |
| REDUXIN CAPS | 51 307 | -2.3% | 32.9% | -1.2 | 277 156 731 | -2.7% | 45.7% | -1 | 1.2% |
| REDUXIN FORTE | 14 156 | 9.0% | 9.1% | 0.7 | 63 823 923 | 12.0% | 10.5% | 1.2 | 1.2% |
| SALVISAR | 35 330 | 4.5% | 1.1% | 0.1 | 13 170 717 | 12.2% | 1.0% | 0.1 | -3.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs